002932 明德生物
已收盘 07-29 15:00:00
资讯
新帖
简况
明德生物:公司重视应收账款管理和收回工作,应收账款情况请关注公司后续披露的定期报告
证券之星 · 07-16
明德生物:公司重视应收账款管理和收回工作,应收账款情况请关注公司后续披露的定期报告
明德生物(002932.SZ)已累计回购3.59%股份 耗资约1.63亿元
智通财经 · 07-01
明德生物(002932.SZ)已累计回购3.59%股份 耗资约1.63亿元
明德生物(002932)6月18日主力资金净卖出621.31万元
证券之星 · 06-19
明德生物(002932)6月18日主力资金净卖出621.31万元
明德生物(002932.SZ)完成回购3.59%股份 耗资1.63亿元
智通财经 · 06-18
明德生物(002932.SZ)完成回购3.59%股份 耗资1.63亿元
明德生物:截止2024年6月7日,公司股东总户数为32841户
证券之星 · 06-12
明德生物:截止2024年6月7日,公司股东总户数为32841户
明德生物(002932)6月6日主力资金净买入1103.41万元
证券之星 · 06-07
明德生物(002932)6月6日主力资金净买入1103.41万元
明德生物(002932.SZ)已耗资1.42亿元回购3.10%股份
智通财经 · 06-06
明德生物(002932.SZ)已耗资1.42亿元回购3.10%股份
明德生物(002932.SZ)已累计回购2.31%股份 耗资约1.08亿元
智通财经 · 06-03
明德生物(002932.SZ)已累计回购2.31%股份 耗资约1.08亿元
明德生物:公司2023年已经开始加强内部管理,从成本、费用、人员结构等多方面着手降本增效
证券之星 · 05-31
明德生物:公司2023年已经开始加强内部管理,从成本、费用、人员结构等多方面着手降本增效
明德生物:公司甲乙流及新冠联合检测试剂盒已获得NMPA和CE认证,产品已向国内和海外销售
证券之星 · 05-21
明德生物:公司甲乙流及新冠联合检测试剂盒已获得NMPA和CE认证,产品已向国内和海外销售
明德生物(002932.SZ)2023年度权益分派:每10股派1.20元
智通财经 · 05-21
明德生物(002932.SZ)2023年度权益分派:每10股派1.20元
明德生物:已回购2.14%股份 成交金额约1亿元
中国财富通 · 05-20
明德生物:已回购2.14%股份 成交金额约1亿元
明德生物(002932.SZ)已累计回购2.14%股份 耗资约1亿元
智通财经 · 05-20
明德生物(002932.SZ)已累计回购2.14%股份 耗资约1亿元
明德生物:公司暂未涉及合成生物领域
证券之星 · 05-08
明德生物:公司暂未涉及合成生物领域
【企业动态】明德生物新增1件法院诉讼,案由为合同纠纷
证券之星 · 05-08
【企业动态】明德生物新增1件法院诉讼,案由为合同纠纷
明德生物(002932.SZ)已耗资7516.75万元回购1.60%股份
智通财经网 · 05-06
明德生物(002932.SZ)已耗资7516.75万元回购1.60%股份
图解明德生物一季报:第一季度单季净利润同比减57.52%
证券之星 · 04-29
图解明德生物一季报:第一季度单季净利润同比减57.52%
明德生物(002932.SZ)发一季度业绩,净利润3205.21万元,同比减少57.52%
智通财经 · 04-29
明德生物(002932.SZ)发一季度业绩,净利润3205.21万元,同比减少57.52%
大手笔!46亿市值的明德生物拟使用不超40亿元购买理财产品
证券之星 · 04-25
大手笔!46亿市值的明德生物拟使用不超40亿元购买理财产品
明德生物(002932.SZ)发2023年度业绩,净利润7492.59万元,同比减少98.22%
智通财经 · 04-25
明德生物(002932.SZ)发2023年度业绩,净利润7492.59万元,同比减少98.22%
暂无数据
公司概况
公司名称:
武汉明德生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2018-07-10
主营业务:
武汉明德生物科技股份有限公司主要从事体外诊断试剂和诊断仪器的研发、生产、销售和服务。公司主要产品和服务覆盖三大领域:体外诊断试剂和仪器、急危重症信息化解决方案、第三方医学检验服务。2022年12月,在中国心血管健康大会上,采用公司信息化解决方案的湖北省英山县人民医院荣获智慧胸痛中心建设最佳解决方案金奖,成为全国唯一一家荣获智慧胸痛中心建设最佳解决方案金奖的县级医院。
发行价格:
20.45
{"stockData":{"symbol":"002932","market":"SZ","secType":"STK","nameCN":"明德生物","latestPrice":15.97,"timestamp":1722236619000,"preClose":16.07,"halted":0,"volume":820190,"delay":0,"floatShares":156000000,"shares":233000000,"eps":0.1356,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.1,"latestTime":"07-29 15:00:00","open":16.09,"high":16.17,"low":15.96,"amount":13153100,"amplitude":0.0131,"askPrice":15.98,"askSize":43,"bidPrice":15.97,"bidSize":15,"shortable":0,"etf":0,"ttmEps":0.1356,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722303000000},"adr":0,"adjPreClose":16.07,"symbolType":"stock","openAndCloseTimeList":[[1722216600000,1722223800000],[1722229200000,1722236400000]],"highLimit":17.68,"lowLimit":14.46,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":232520957,"pbRate":0.62,"roa":"--","roe":"0.53%","epsLYR":0.33,"committee":0.202454,"marketValue":3713000000,"floatMarketCap":2493000000,"peRate":117.772861,"changeRate":-0.0062,"turnoverRate":0.0053,"status":1},"requestUrl":"/m/hq/s/002932/tweets","defaultTab":"tweets","newsList":[{"id":"2451961347","title":"明德生物:公司重视应收账款管理和收回工作,应收账款情况请关注公司后续披露的定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2451961347","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451961347?lang=zh_cn&edition=full","pubTime":"2024-07-16 18:01","pubTimestamp":1721124083,"startTime":"0","endTime":"0","summary":"投资者:注意到公司应收账款周转天数为1678天,是否存在有难以收回的应收账款?公司对此有无应对措施?公司目前正积极推进应收账款问题的解决,包括采用法律途径加强应收账款的催收力度,维护公司合法权益。谢谢明德生物董秘:尊敬的投资者您好,截止2024年7月10日,公司股东总户数为31757户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600036360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2448996633","title":"明德生物(002932.SZ)已累计回购3.59%股份 耗资约1.63亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448996633","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448996633?lang=zh_cn&edition=full","pubTime":"2024-07-01 19:29","pubTimestamp":1719833358,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)发布公告,截止到2024年6月30日,公司通过回购专用证券账户以集中竞价方式回购公司股份834.97万股,占公司总股本的3.59%;回购股份最高成交价为20.98元/股,最低成交价为18.17元/股,总成交金额为人民币1.63亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1143773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2444499788","title":"明德生物(002932)6月18日主力资金净卖出621.31万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444499788","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444499788?lang=zh_cn&edition=full","pubTime":"2024-06-19 09:17","pubTimestamp":1718759863,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月18日收盘,明德生物报收于18.18元,下跌1.41%,换手率0.98%,成交量1.53万手,成交额2808.36万元。近5日资金流向一览见下表:明德生物融资融券信息显示,融资方面,当日融资买入556.15万元,融资偿还546.78万元,融资净买入9.37万元,连续3日净买入累计691.8万元。明德生物主营业务:主要从事体外诊断试剂和诊断仪器的研发、生产、销售和服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061900014921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2444485321","title":"明德生物(002932.SZ)完成回购3.59%股份 耗资1.63亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444485321","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444485321?lang=zh_cn&edition=full","pubTime":"2024-06-18 19:14","pubTimestamp":1718709275,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)公告,公司本次用于维护公司价值及股东权益的股份回购的实际回购时间区间为2024年3月27日至2024年6月17日,公司通过股份回购专用证券账户以集中竞价交易方式累计回购公司股份数834.97万股,占公司总股本的3.59%,最高成交价为20.98元/股,最低成交价为18.17元/股,支付总金额为1.63亿元(不含交易费用)。公司本次回购方案中维护公司价值及股东权益部分的股份回购已实施完毕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1136951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2442340415","title":"明德生物:截止2024年6月7日,公司股东总户数为32841户","url":"https://stock-news.laohu8.com/highlight/detail?id=2442340415","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442340415?lang=zh_cn&edition=full","pubTime":"2024-06-12 19:01","pubTimestamp":1718190079,"startTime":"0","endTime":"0","summary":"证券之星消息,明德生物(002932)06月12日在投资者关系平台上答复投资者关心的问题。投资者:请问截止6月7日盘后公司登记在册的股东人数是多少?谢谢明德生物董秘:尊敬的投资者您好,截止2024年6月7日,公司股东总户数为32841户。感谢您的关注!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061200035659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2441708268","title":"明德生物(002932)6月6日主力资金净买入1103.41万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441708268","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441708268?lang=zh_cn&edition=full","pubTime":"2024-06-07 09:20","pubTimestamp":1717723222,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月6日收盘,明德生物报收于18.48元,下跌0.48%,换手率1.66%,成交量2.59万手,成交额4755.84万元。近5日资金流向一览见下表:明德生物融资融券信息显示,融资方面,当日融资买入568.94万元,融资偿还456.74万元,融资净买入112.2万元。明德生物主营业务:主要从事体外诊断试剂和诊断仪器的研发、生产、销售和服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060700012307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2441279297","title":"明德生物(002932.SZ)已耗资1.42亿元回购3.10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2441279297","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441279297?lang=zh_cn&edition=full","pubTime":"2024-06-06 18:47","pubTimestamp":1717670829,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)发布公告,截至到2024年6月6日,公司累计通过回购专用证券账户以集中竞价方式回购公司股份720.15万股,占公司总股本的3.10%;回购股份最高成交价为20.98元/股,最低成交价为18.17元/股,总成交金额为人民币1.42亿元(不含交易税费)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1132211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2440465434","title":"明德生物(002932.SZ)已累计回购2.31%股份 耗资约1.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440465434","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440465434?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:45","pubTimestamp":1717411523,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)发布公告,截止到2024年5月31日,公司通过回购专用证券账户以集中竞价方式回购公司股份536.7万股,占公司总股本的2.31%;回购股份最高成交价为20.98元/股,最低成交价为18.60元/股,总成交金额为人民币1.08亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1130217.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2439320962","title":"明德生物:公司2023年已经开始加强内部管理,从成本、费用、人员结构等多方面着手降本增效","url":"https://stock-news.laohu8.com/highlight/detail?id=2439320962","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439320962?lang=zh_cn&edition=full","pubTime":"2024-05-31 19:01","pubTimestamp":1717153268,"startTime":"0","endTime":"0","summary":"证券之星消息,明德生物05月31日在投资者关系平台上答复投资者关心的问题。贵公司2023年末在职职工1063人,全年领薪酬人员1742人,请问贵公司至2024年5月底在职职工、全年领薪酬人员分别是多少人?明德生物董秘:尊敬的投资者您好,公司2023年已经开始加强内部管理,从成本、费用、人员结构等多方面着手降本增效。公司将继深耕主业,持续做好生产经营工作,进一步提升运营管理效率。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024053100039224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2437413031","title":"明德生物:公司甲乙流及新冠联合检测试剂盒已获得NMPA和CE认证,产品已向国内和海外销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2437413031","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437413031?lang=zh_cn&edition=full","pubTime":"2024-05-21 19:01","pubTimestamp":1716289283,"startTime":"0","endTime":"0","summary":"证券之星消息,明德生物(002932)05月21日在投资者关系平台上答复投资者关心的问题。投资者:尊敬的董秘您好!请问贵公司的三联检产品在哪些地区有销售?销售前景怎么样?有没有计划在美国地区认证?明德生物董秘:尊敬的投资者您好,公司甲乙流及新冠联合检测试剂盒已获得NMPA和CE认证,产品已向国内和海外销售。感谢您的关注!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052100031445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2437418330","title":"明德生物(002932.SZ)2023年度权益分派:每10股派1.20元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437418330","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437418330?lang=zh_cn&edition=full","pubTime":"2024-05-21 18:44","pubTimestamp":1716288291,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)发布公告,公司2023年年度利润分配方案为:以现有总股本剔除已回购股份后为基数,向全体股东每10股派1.20元人民币现金(含税),本次权益分派的股权登记日为:2024年5月27日,除权除息日为:2024年5月28日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1124014.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2436417565","title":"明德生物:已回购2.14%股份 成交金额约1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2436417565","media":"中国财富通","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436417565?lang=zh_cn&edition=full","pubTime":"2024-05-20 18:08","pubTimestamp":1716199692,"startTime":"0","endTime":"0","summary":"中国财富通5月20日 - 明德生物(002932)公告称,截至5月20日,公司累计通过回购专用证券账户以集中竞价方式回购公司股份4,966,031股,占公司总股本的2.14%;回购股份最高成交价为20.98元/股,最低成交价为19.30元/股,总成交金额为人民币100,042,919.81元(不含交易税费)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=uoVtsumsTpM%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2436012727","title":"明德生物(002932.SZ)已累计回购2.14%股份 耗资约1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2436012727","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436012727?lang=zh_cn&edition=full","pubTime":"2024-05-20 17:17","pubTimestamp":1716196646,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)发布公告,截至到2024年5月20日,公司累计通过回购专用证券账户以集中竞价方式回购公司股份496.6万股,占公司总股本的2.14%;回购股份最高成交价为20.98元/股,最低成交价为19.30元/股,总成交金额为人民币1亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1123281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2433411767","title":"明德生物:公司暂未涉及合成生物领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2433411767","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433411767?lang=zh_cn&edition=full","pubTime":"2024-05-08 19:01","pubTimestamp":1715166075,"startTime":"0","endTime":"0","summary":"证券之星消息,明德生物05月08日在投资者关系平台上答复投资者关心的问题。投资者:2022年贵公司与北京君远,君联和泰,康哲创业共同投资的合成生物项目进展如何了?本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800034019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2433753036","title":"【企业动态】明德生物新增1件法院诉讼,案由为合同纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2433753036","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433753036?lang=zh_cn&edition=full","pubTime":"2024-05-08 05:32","pubTimestamp":1715117575,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,4月29日明德生物(002932)新增1件法院诉讼如下:案号:(2024)鄂0192民初6660号法院:武汉东湖新技术开发区人民法院案由:合同纠纷原告:郑州市柘丘特技术服务有限公司被告:深圳市铭辰自动化科技有限公司、武汉明德生物科技股份有限公司案件类型:民事立案日期:2024年4月29日数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800007893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2433644727","title":"明德生物(002932.SZ)已耗资7516.75万元回购1.60%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2433644727","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433644727?lang=zh_cn&edition=full","pubTime":"2024-05-06 18:11","pubTimestamp":1714990308,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)发布公告,截止到2024年4月30日,公司通过回购专用证券账户以集中竞价方式回购公司股份372.96万股,占公司总股本的1.60%;回购股份最高成交价为20.98元/股,最低成交价为19.3元/股,总成交金额为人民币7516.75万元(不含交易税费)。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2431353880","title":"图解明德生物一季报:第一季度单季净利润同比减57.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431353880","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431353880?lang=zh_cn&edition=full","pubTime":"2024-04-29 17:44","pubTimestamp":1714383899,"startTime":"0","endTime":"0","summary":"证券之星消息,明德生物2024年一季报显示,公司主营收入6096.34万元,同比下降83.63%;归母净利润3205.21万元,同比下降57.52%;扣非净利润-1597.06万元,同比下降133.22%;负债率12.88%,投资收益2685.69万元,财务费用-262.72万元,毛利率40.28%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900023014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932"],"gpt_icon":0},{"id":"2431275885","title":"明德生物(002932.SZ)发一季度业绩,净利润3205.21万元,同比减少57.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431275885","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431275885?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:57","pubTimestamp":1714381066,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)发布2024年第一季度报告,报告期内公司实现营业收入6096.34万元,同比减少83.63%;归属于上市公司股东的净利润3205.21万元,同比减少57.52%;归属于上市公司股东扣除非经常性损益净亏损1597.06万元;基本每股收益0.14元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002932"],"gpt_icon":0},{"id":"2430178281","title":"大手笔!46亿市值的明德生物拟使用不超40亿元购买理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2430178281","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430178281?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:51","pubTimestamp":1714053117,"startTime":"0","endTime":"0","summary":"4月25日晚,明德生物发布公告宣布,公司及其下属公司计划使用总计不超过40亿元人民币的闲置自有资金进行委托理财,购买低风险理财产品。值得注意的是,截至4月25日收盘,明德生物股价报收19.91元,总市值46.29亿。针对投资风险方面,明德生物也直言,以上额度内资金只能购买不超过十二个月低风险理财产品,不得用于证券投资,不得购买除低风险金融理财产品以外的其他理财产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024042500045957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2430447027","title":"明德生物(002932.SZ)发2023年度业绩,净利润7492.59万元,同比减少98.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430447027","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430447027?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:43","pubTimestamp":1714041822,"startTime":"0","endTime":"0","summary":"智通财经APP讯,明德生物(002932.SZ)发布2023年年度报告,营业收入7.5亿元,同比减少92.88%。归属于上市公司股东的净利润7492.59万元,同比减少98.22%。公司股东的扣除非经常性损益的净亏损1.24亿元,基本每股收益0.33元,向全体股东每10股派发现金红利1.20元(含税),不送红股,不以公积金转增股本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002932"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-07-10","address":"湖北省武汉市江夏区东湖新技术开发区高新二路388号武汉光谷国际生物医药企业加速器3.1期25栋1层(3)厂房三号","stockEarnings":[{"period":"1week","weight":-0.0423},{"period":"1month","weight":-0.0817},{"period":"3month","weight":-0.1745},{"period":"6month","weight":-0.1906},{"period":"1year","weight":-0.345},{"period":"ytd","weight":-0.296}],"companyName":"武汉明德生物科技股份有限公司","boardCode":"AI0027","perCapita":"4914股","boardName":"医药制造业","registeredCapital":"23252万元","compareEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.0275},{"period":"3month","weight":-0.064},{"period":"6month","weight":-0.0066},{"period":"1year","weight":-0.1013},{"period":"ytd","weight":-0.0282}],"survey":" 武汉明德生物科技股份有限公司主要从事体外诊断试剂和诊断仪器的研发、生产、销售和服务。公司主要产品和服务覆盖三大领域:体外诊断试剂和仪器、急危重症信息化解决方案、第三方医学检验服务。2022年12月,在中国心血管健康大会上,采用公司信息化解决方案的湖北省英山县人民医院荣获智慧胸痛中心建设最佳解决方案金奖,成为全国唯一一家荣获智慧胸痛中心建设最佳解决方案金奖的县级医院。","serverTime":1722252205362,"listedPrice":20.45,"stockholders":"31757人(较上一季度减少3.30%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"明德生物(002932)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供明德生物(002932)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"明德生物,002932,明德生物股票,明德生物股票老虎,明德生物股票老虎国际,明德生物行情,明德生物股票行情,明德生物股价,明德生物股市,明德生物股票价格,明德生物股票交易,明德生物股票购买,明德生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"明德生物(002932)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供明德生物(002932)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}